EVALUATING THE OCCURRENCE OF ADVERSE EVENTS AMONG PEDIATRIC PATIENTS EXPOSED TO INTRAVENOUS LACOSAMIDE (VIMPATĀ®) USING REAL WORLD DATA

30/01/2020
02/07/2024
EU PAS number:
EUPAS32597
Study
Finalised

ENCePP Code of conduct

No
Data sources

Data sources (types)

Administrative healthcare records (e.g., claims)
Electronic healthcare records (EHR)
Other

Data sources (types), other

PEDSNet, pediatric electronic medical records from secondary care source.
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No